The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Joint Diseases and Related Surgery is an esteemed academic journal published by the TURKISH JOINT DISEASES FOUNDATION, focusing on the multifaceted field of orthopedics, sports medicine, and rehabilitation. Since its inception in 2020, this journal has quickly established itself as a key resource within the medical community, evidenced by its recognition in the 2023 category quartiles, where it holds a commendable Q2 ranking in Orthopedics and Sports Medicine, Rehabilitation, and Surgery. With an E-ISSN of 2687-4792 and a robust presence in Scopus, it ranks impressively within its respective fields, further illustrating its significance in advancing scholarly discourse and research. The journal welcomes a myriad of contributions, including original research, reviews, and clinical studies, facilitating the exchange of knowledge aimed at improving patient outcomes and enhancing clinical practices. By prioritizing open accessibility, it ensures that vital research is readily available to researchers, professionals, and students alike, fostering a collaborative environment in the pursuit of scientific advancement.

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.

Arthroplasty, published by BMC, is a prestigious open-access journal dedicated to disseminating cutting-edge research in the fields of orthopedics and sports medicine, as well as surgical advancements. Since its inception in 2019, this journal has rapidly established itself as a leading platform for scholars and clinicians alike, with a remarkable position in the 2023 category quartiles—ranking Q2 in Orthopedics and Sports Medicine and Q1 in Surgery. Based in the United Kingdom, at CAMPUS, 4 Crinan St, London, the journal promotes unrestricted access to valuable research findings, fostering a collaborative environment for professionals aiming to improve surgical outcomes and patient care. With its current Scopus ranks of #250 in Medicine (Surgery) and #180 in Medicine (Orthopedics and Sports Medicine), Arthroplasty is an essential resource for researchers, professionals, and students aiming to remain at the forefront of their fields. As the journal continues to evolve over the converged years from 2019 to 2024, it remains committed to enhancing the quality and accessibility of orthopedic research.

The HSS Journal, published by SAGE Publications Inc, is a prominent scholarly journal dedicated to advancing knowledge in the fields of Orthopedics, Sports Medicine, and Surgery. With a robust ISSN of 1556-3316 and E-ISSN 1556-3324, this journal has been rigorously contributing to the medical community since its inception in 2006, with a convergence set to last through 2024. The journal boasts a commendable impact factor, positioning it in the Q2 category for both Orthopedics and Sports Medicine, as well as Surgery, highlighting its significance and credibility within these domains. The HSS Journal's Scopus rankings further underscore its scholarly impact, placing it in the 75th percentile for Surgery and 67th percentile for Orthopedics and Sports Medicine. Dedicated to providing high-quality, peer-reviewed articles, the journal serves as an essential resource for researchers, clinicians, and students eager to stay abreast of the latest advancements and best practices in surgical care and orthopedics.

Bone & Joint Open, an esteemed journal published by the British Editorial Society of Bone & Joint Surgery, represents a significant advancement in the dissemination of research in the field of orthopedics and sports medicine. With an E-ISSN of 2633-1462, this Open Access journal has been providing unrestricted access to high-quality research since its inception in 2020, making it a pivotal resource for researchers, clinicians, and students alike. The journal boasts an impressive Q1 ranking in both Orthopedics and Sports Medicine and Surgery categories, affirming its impact and relevance in an increasingly competitive academic landscape. Furthermore, it ranks #81 out of 551 in the discipline of Medicine Surgery and #66 out of 321 in Orthopedics and Sports Medicine, reflecting its high standards of publication and contribution to the field. Located in the heart of the United Kingdom, Bone & Joint Open aims to facilitate the exchange of innovative research and critical advancements, ensuring that all stakeholders have access to essential findings that drive the evolution of surgical practices and orthopedic care.

ORTHOPEDIC CLINICS OF NORTH AMERICA, published by W B Saunders Co-Elsevier Inc., is a leading peer-reviewed journal in the field of orthopedics and sports medicine, established in 1970 and continuing to be influential through 2024. With an ISSN of 0030-5898 and an E-ISSN of 1558-1373, it is recognized for its rigorous academic standards, achieving a Q2 ranking in the 2023 Scopus category for orthopedics and sports medicine, placing it in the 67th percentile among its peers. This journal provides a comprehensive range of scholarly articles, clinical studies, and reviews designed to advance orthopedic knowledge and enhance patient care. While the journal currently does not offer open access options, it remains accessible to professionals, researchers, and students who seek to stay updated with the latest advancements and trends in orthopedics. By disseminating critical research findings and clinical insights, ORTHOPEDIC CLINICS OF NORTH AMERICA plays a vital role in shaping the future of orthopedic practice and education.

The JOURNAL OF ORTHOPAEDIC RESEARCH, published by WILEY, stands as a premier peer-reviewed journal in the field of orthopedics and sports medicine, showcasing high-impact research with a notable impact factor and categorized in the top Q1 quartile for 2023. Since its inception in 1983, this journal has continuously evolved to meet the needs of a dynamic scientific community, serving as a vital resource for researchers, clinicians, and students engaged in the study and practice of orthopedics. With commendable rankings, positioned at Rank #47 out of 321 in the Medicine Orthopedics and Sports Medicine category, and boasting a remarkable 85th percentile in Scopus rankings, it highlights groundbreaking studies and advances in orthopedic science. While not an open-access journal, it provides diverse access options to ensure that its contributions are available to a broad academic audience. The journal plays a crucial role in disseminating innovative ideas and fostering collaboration within the orthopedic research community, thereby promoting improved patient care and outcomes in musculoskeletal health.